Saba Azarnoush
Overview
Explore the profile of Saba Azarnoush including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avoine J, Harroche A, Azarnoush S, Huguenin Y, Blandinieres A, De Raucourt E, et al.
Thromb Res
. 2025 Feb;
247:109282.
PMID: 39947108
No abstract available.
2.
Simonin M, Lainey E, Rialland F, Caye-Eude A, Reguerre Y, Boutroux H, et al.
Bull Cancer
. 2024 Nov;
PMID: 39492072
Acute leukemias of ambiguous lineage (ALAL) represent between 3 and 5% of childhood AL. This term encompasses many subtypes of AL that have been defined according to the immunophenotypic profile...
3.
Thalhammer J, Jeziorski E, Marec-Berard P, Barkaoui M, Barkaoui M, Pagnier A, et al.
Blood
. 2024 Nov;
145(10):1061-1073.
PMID: 39486044
Hematological involvement (HI) is one of the life-threatening risk organs (ROs) in Langerhans cell histiocytosis (LCH). Lahey criteria have defined HI since 1975 as hemoglobin <10 g/dL, platelets <100 ×...
4.
Hoshino A, Picard B, Polychronopoulou S, Kelaidi C, Azarnoush S, Kracker S, et al.
J Allergy Clin Immunol
. 2024 Mar;
154(1):229-236.e2.
PMID: 38438084
Background: Immune dysregulation often presents as autoimmunity, inflammation, and/or lymphoproliferation. Several germline genetic defects have been associated with immune dysregulation; they include heterozygous gain-of-function (GOF) mutations in IKZF1, an essential...
5.
Maccari M, Wolkewitz M, Schwab C, Lorenzini T, Leiding J, Aladjdi N, et al.
J Allergy Clin Immunol
. 2023 Jun;
152(4):984-996.e10.
PMID: 37390899
Background: Activated phosphoinositide-3-kinase δ syndrome (APDS) is an inborn error of immunity (IEI) with infection susceptibility and immune dysregulation, clinically overlapping with other conditions. Management depends on disease evolution, but...
6.
Helias-Rodzewicz Z, Donadieu J, Terrones N, Barkaoui M, Lambilliotte A, Moshous D, et al.
Am J Hematol
. 2023 Apr;
98(7):1058-1069.
PMID: 37115038
The spectrum of somatic mutations in pediatric histiocytoses and their clinical implications are not fully characterized, especially for non-Langerhans cell histiocytosis (-LCH) subtypes. A cohort of 415 children with histiocytosis...
7.
Dhunputh C, Strullu M, Petit A, Merched M, Pasquet M, Azarnoush S, et al.
Br J Haematol
. 2022 Apr;
198(2):373-381.
PMID: 35438187
Despite major therapeutic improvements, children with relapsed/refractory Acute Myeloid Leukaemia still have poor outcomes and overall survival does not exceed 40%. New treatments are required to improve their outcome; Gemtuzumab...
8.
Tourret M, Talvard-Balland N, Lambert M, Ben Youssef G, Chevalier M, Bohineust A, et al.
J Immunother Cancer
. 2021 Oct;
9(10).
PMID: 34615705
Background: Mucosal-associated invariant T (MAIT) cells are semi-invariant T cells that recognize microbial antigens presented by the highly conserved MR1 molecule. MAIT cells are predominantly localized in the liver and...
9.
Moreno-Corona N, Chentout L, Poggi L, Thouenon R, Masson C, Parisot M, et al.
Front Pediatr
. 2021 Jul;
9:688022.
PMID: 34249818
Activated PI3-kinase-δ syndrome 2 (APDS2) is caused by autosomal dominant mutations in the gene encoding the p85α, p55α, and p50α regulatory subunits. Most diagnosed APDS2 patients carry mutations affecting either...
10.
Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease
Gille A, Pondarre C, Dalle J, Bernaudin F, Chalas C, Fahd M, et al.
Blood
. 2020 Dec;
137(6):856-859.
PMID: 33259585
No abstract available.